Acute Intermittent Porphyria in a Man with Dual Enzyme Deficiencies.

Case Reports in Genetics Pub Date : 2020-10-15 eCollection Date: 2020-01-01 DOI:10.1155/2020/8873219
G N Cerbino, L Abou Assali, L S Varela, L Tomassi, A Batlle, V E Parera, M V Rossetti
{"title":"Acute Intermittent Porphyria in a Man with Dual Enzyme Deficiencies.","authors":"G N Cerbino,&nbsp;L Abou Assali,&nbsp;L S Varela,&nbsp;L Tomassi,&nbsp;A Batlle,&nbsp;V E Parera,&nbsp;M V Rossetti","doi":"10.1155/2020/8873219","DOIUrl":null,"url":null,"abstract":"<p><p>Porphyrias are a heterogeneous group of metabolic disorders that result from the altered activity of specific enzymes of the heme biosynthetic pathway and are characterized by accumulation of pathway intermediates. Porphyria cutanea tarda (PCT) is the most common porphyria and is due to deficient activity of uroporphyrinogen decarboxylase (UROD). Acute intermittent porphyria (AIP) is the most common of the acute hepatic porphyrias, caused by decreased activity of hydroxymethylbilane synthase (HMBS). An Argentinean man with a family history of PCT who carried the <i>UROD</i> variant c.10_11insA suffered severe abdominal pain. Biochemical testing was consistent with AIP, and molecular analysis of <i>HMBS</i> revealed a <i>de novo</i> variant: c.344 + 2_ + 5delTAAG. This is one of the few cases of porphyria identified with both <i>UROD</i> and <i>HMBS</i> mutations and the first confirmed case of porphyria with dual enzyme deficiencies in Argentina.</p>","PeriodicalId":30325,"journal":{"name":"Case Reports in Genetics","volume":"2020 ","pages":"8873219"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8873219","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8873219","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Porphyrias are a heterogeneous group of metabolic disorders that result from the altered activity of specific enzymes of the heme biosynthetic pathway and are characterized by accumulation of pathway intermediates. Porphyria cutanea tarda (PCT) is the most common porphyria and is due to deficient activity of uroporphyrinogen decarboxylase (UROD). Acute intermittent porphyria (AIP) is the most common of the acute hepatic porphyrias, caused by decreased activity of hydroxymethylbilane synthase (HMBS). An Argentinean man with a family history of PCT who carried the UROD variant c.10_11insA suffered severe abdominal pain. Biochemical testing was consistent with AIP, and molecular analysis of HMBS revealed a de novo variant: c.344 + 2_ + 5delTAAG. This is one of the few cases of porphyria identified with both UROD and HMBS mutations and the first confirmed case of porphyria with dual enzyme deficiencies in Argentina.

Abstract Image

Abstract Image

Abstract Image

双酶缺乏症患者急性间歇性卟啉症。
卟啉症是一种异质性代谢疾病,由血红素生物合成途径中特定酶的活性改变引起,其特征是途径中间体的积累。迟发性皮肤卟啉症(PCT)是最常见的卟啉症,是由于缺乏活性的尿卟啉原脱羧酶(UROD)。急性间歇性卟啉症(AIP)是最常见的急性肝性卟啉症,由羟甲基双烷合成酶(HMBS)活性降低引起。一名有PCT家族史的阿根廷男子携带UROD变体c.10_11insA,患有严重的腹痛。生化检测与AIP一致,分子分析显示HMBS有一个新的变异:c.344 + 2_ + 5delTAAG。这是少数同时具有UROD和HMBS突变的卟啉症病例之一,也是阿根廷首例双酶缺乏症卟啉症确诊病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
21
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信